MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 108 filers reported holding MAXCYTE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,116,419 | -32.6% | 357,827 | -0.9% | 0.00% | – |
| Q2 2023 | $1,657,623 | -11.8% | 361,138 | -4.9% | 0.00% | – |
| Q1 2023 | $1,880,000 | +112205.9% | 379,855 | +23.9% | 0.00% | – |
| Q4 2022 | $1,674 | -99.9% | 306,557 | +14.1% | 0.00% | – |
| Q3 2022 | $1,746,000 | +43.1% | 268,760 | +4.1% | 0.00% | – |
| Q2 2022 | $1,220,000 | +60.1% | 258,152 | +137.1% | 0.00% | – |
| Q1 2022 | $762,000 | -26.2% | 108,886 | +7.6% | 0.00% | – |
| Q4 2021 | $1,032,000 | +331.8% | 101,239 | +415.8% | 0.00% | – |
| Q3 2021 | $239,000 | – | 19,626 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH RUN CAPITAL, LP | 480,900 | $3,361,000 | 4.94% |
| Casdin Capital, LLC | 13,971,334 | $97,660,000 | 4.38% |
| Vitruvian Partners LLP | 4,385,670 | $30,656,000 | 3.25% |
| RIVER GLOBAL INVESTORS LLP | 2,100,000 | $14,849,000 | 1.95% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $1,258,000 | 1.52% |
| Pier Capital, LLC | 1,017,753 | $7,114,000 | 0.91% |
| First Light Asset Management, LLC | 1,321,406 | $9,237,000 | 0.82% |
| Montanaro Asset Management Ltd | 929,000 | $6,557,000 | 0.81% |
| Nicholas Investment Partners, LP | 776,963 | $5,431,000 | 0.39% |
| Bleichroeder LP | 250,000 | $1,764,000 | 0.31% |